These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11738466)

  • 1. Determinants of multiple psychotropic drug use in patients with mild intellectual disabilities or borderline intellectual functioning and psychiatric or behavioral disorders.
    Stolker JJ; Heerdink ER; Leufkens HG; Clerkx MG; Nolen WA
    Gen Hosp Psychiatry; 2001; 23(6):345-9. PubMed ID: 11738466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study.
    Sheehan R; Hassiotis A; Walters K; Osborn D; Strydom A; Horsfall L
    BMJ; 2015 Sep; 351():h4326. PubMed ID: 26330451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Borderline intellectual functioning is associated with poor social functioning, increased rates of psychiatric diagnosis and drug use--a cross sectional population based study.
    Gigi K; Werbeloff N; Goldberg S; Portuguese S; Reichenberg A; Fruchter E; Weiser M
    Eur Neuropsychopharmacol; 2014 Nov; 24(11):1793-7. PubMed ID: 25224107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and characteristics of psychotropic drug use in institutionalized children and adolescents with mild intellectual disability.
    Scheifes A; de Jong D; Stolker JJ; Nijman HL; Egberts TC; Heerdink ER
    Res Dev Disabil; 2013 Oct; 34(10):3159-67. PubMed ID: 23886758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of Psychotropic Polypharmacy Among Outpatients With Psychiatric Disorders and Intellectual Disability.
    Lunsky Y; Modi M
    Psychiatr Serv; 2018 Feb; 69(2):242-246. PubMed ID: 29089006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatric disorders in outpatients with borderline intellectual functioning: comparison with both outpatients from regular mental health care and outpatients with mild intellectual disabilities.
    Wieland J; Kapitein-de Haan S; Zitman FG
    Can J Psychiatry; 2014 Apr; 59(4):213-9. PubMed ID: 25007114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychotropic prescribing for persons with intellectual disabilities and other psychiatric disorders.
    Edelsohn GA; Schuster JM; Castelnovo K; Terhorst L; Parthasarathy M
    Psychiatr Serv; 2014 Feb; 65(2):201-7. PubMed ID: 24233105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of previously undiagnosed psychiatric disorders in persons with developmental disabilities decreased or eliminated self-injurious behavior.
    Tsiouris JA; Cohen IL; Patti PJ; Korosh WM
    J Clin Psychiatry; 2003 Sep; 64(9):1081-90. PubMed ID: 14628984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychopharmacoepidemiology of mental retardation: 1966 to 1995.
    Singh NN; Ellis CR; Wechsler H
    J Child Adolesc Psychopharmacol; 1997; 7(4):255-66. PubMed ID: 9542696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse events and the relation with quality of life in adults with intellectual disability and challenging behaviour using psychotropic drugs.
    Scheifes A; Walraven S; Stolker JJ; Nijman HL; Egberts TC; Heerdink ER
    Res Dev Disabil; 2016; 49-50():13-21. PubMed ID: 26647003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, patterns and factors associated with psychotropic use in older adults with intellectual disabilities in Ireland.
    O'Dwyer M; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC
    J Intellect Disabil Res; 2017 Oct; 61(10):969-983. PubMed ID: 28639298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychotropic drug use in intellectually disabled group-home residents with behavioural problems.
    Stolker JJ; Koedoot PJ; Heerdink ER; Leufkens HG; Nolen WA
    Pharmacopsychiatry; 2002 Jan; 35(1):19-23. PubMed ID: 11819154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of psychotropic drug use in adults with intellectual disability: positive and negative findings from a large scale study.
    Tsiouris JA; Kim SY; Brown WT; Pettinger J; Cohen IL
    J Autism Dev Disord; 2013 Mar; 43(3):719-31. PubMed ID: 22829245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determinants of psychotropic medication in adults with mild or moderate intellectual disabilities].
    Schützwohl M; Voss E; Stiawa M; Salize HJ; Puschner B; Koch A
    Nervenarzt; 2017 Nov; 88(11):1273-1280. PubMed ID: 27638741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in the use of psychotropic drugs in people with intellectual disability in Taiwan: a nationwide outpatient service study, 1997-2007.
    Hsu SW; Chiang PH; Chang YC; Lin JD; Tung HJ; Chen CY
    Res Dev Disabil; 2014 Feb; 35(2):364-72. PubMed ID: 24333807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Blind Spot? Screening for Mild Intellectual Disability and Borderline Intellectual Functioning in Admitted Psychiatric Patients: Prevalence and Associations with Coercive Measures.
    Nieuwenhuis JG; Noorthoorn EO; Nijman HL; Naarding P; Mulder CL
    PLoS One; 2017; 12(2):e0168847. PubMed ID: 28151977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Problem behaviours and psychotropic medication use in intellectual disability: a multinational cross-sectional survey.
    Perry BI; Cooray SE; Mendis J; Purandare K; Wijeratne A; Manjubhashini S; Dasari M; Esan F; Gunaratna I; Naseem RA; Hoare S; Chester V; Roy A; Devapriam J; Alexander R; Kwok HF
    J Intellect Disabil Res; 2018 Feb; 62(2):140-149. PubMed ID: 29349928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mental illness and psychotropic drug use among prescription drug overdose deaths: a medical examiner chart review.
    Toblin RL; Paulozzi LJ; Logan JE; Hall AJ; Kaplan JA
    J Clin Psychiatry; 2010 Apr; 71(4):491-6. PubMed ID: 20409446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance use in individuals with mild to borderline intellectual disability: A comparison between self-report, collateral-report and biomarker analysis.
    VanDerNagel JE; Kiewik M; van Dijk M; Didden R; Korzilius HP; van der Palen J; Buitelaar JK; Uges DR; Koster RA; de Jong CA
    Res Dev Disabil; 2017 Apr; 63():151-159. PubMed ID: 27133469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for intellectual disabilities and borderline intelligence in Dutch outpatients with severe mental illness.
    Seelen-de Lang BL; Smits HJH; Penterman BJM; Noorthoorn EO; Nieuwenhuis JG; Nijman HLI
    J Appl Res Intellect Disabil; 2019 Sep; 32(5):1096-1102. PubMed ID: 31033102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.